These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24482151)

  • 41. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.
    Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y
    J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Auditory cortical function during verbal episodic memory encoding in Alzheimer's disease.
    Dhanjal NS; Warren JE; Patel MC; Wise RJ
    Ann Neurol; 2013 Feb; 73(2):294-302. PubMed ID: 23281111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of patients with mild cognitive impairment and mild to moderate dementia.
    Vandewoude MF
    Acta Clin Belg; 2009; 64(2):92-9. PubMed ID: 19432021
    [No Abstract]   [Full Text] [Related]  

  • 44. Detection and Prevention of Cognitive Decline.
    Small GW
    Am J Geriatr Psychiatry; 2016 Dec; 24(12):1142-1150. PubMed ID: 27745823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Citicoline: pharmacological and clinical review, 2016 update.
    Secades JJ
    Rev Neurol; 2016 Dec; 63(S03):S1-S73. PubMed ID: 28417449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug prescription in mild cognitive impairment: the physicians' perspective in Italy.
    Frisoni GB; Canu E; Geroldi C; Zanetti O; Zacchi V
    Int J Geriatr Psychiatry; 2006 Nov; 21(11):1071-7. PubMed ID: 16955446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hierarchical Bayesian cognitive processing models to analyze clinical trial data.
    Shankle WR; Hara J; Mangrola T; Hendrix S; Alva G; Lee MD
    Alzheimers Dement; 2013 Jul; 9(4):422-8. PubMed ID: 23123230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, Synthesis and Molecular Docking Studies of New Potential Piperazine Derivatives as Cognition Enhancers.
    Danta CC; Piplani P
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):157-170. PubMed ID: 27758699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms.
    Epperly T; Dunay MA; Boice JL
    Am Fam Physician; 2017 Jun; 95(12):771-778. PubMed ID: 28671413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.
    Popp J; Arlt S
    Curr Opin Psychiatry; 2011 Nov; 24(6):556-61. PubMed ID: 21934621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial.
    Sano M; Aisen PS; Andrews HF; Tsai WY; Lai F; Dalton AJ;
    Neurology; 2016 May; 86(22):2071-6. PubMed ID: 27164691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Mind Bending Quest for Cognitive Enhancers.
    Arce E; Ehlers MD
    Clin Pharmacol Ther; 2017 Feb; 101(2):179-181. PubMed ID: 27706806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats.
    Shi C; Yi D; Li Z; Zhou Y; Cao Y; Sun Y; Chui D; Guo X
    Behav Brain Res; 2017 Mar; 322(Pt A):167-176. PubMed ID: 28115220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug may temporarily slow progression of mild cognitive impairment.
    Mayo Clin Womens Healthsource; 2005 Aug; 9(8):3. PubMed ID: 16015194
    [No Abstract]   [Full Text] [Related]  

  • 55. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 56. Revisiting choline alphoscerate profile: a new, perspective, role in dementia?
    Scapicchio PL
    Int J Neurosci; 2013 Jul; 123(7):444-9. PubMed ID: 23387341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC; Diehl LA; Hedgepath AW
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract]   [Full Text] [Related]  

  • 58. URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy.
    Wang D; Lin Q; Su S; Liu K; Wu Y; Hai J
    Neuroscience; 2017 Mar; 344():293-304. PubMed ID: 28042028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Donepezil in the treatment of musical hallucinations.
    Ukai S; Yamamoto M; Tanaka M; Shinosaki K; Takeda M
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):190-2. PubMed ID: 17362438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.